Huntington's Disease Research

Huntington's disease is a neurodegenerative disease characterized by cognitive decline and motor dysfunction. It is a genetic disorder which results in the production of mutant huntingtin protein (mHtt). This protein aggregates in the cell cytoplasm and nucleus, affecting cellular function.

Huntington's Disease Research Products Targets

Products for Huntington's Disease Research - Page 41

Cat.No. Product Name Information/Activity
BCC7627 LY 487379 hydrochloride 353229-59-1
BCC6343 ML 289 1382481-79-9
BCC6345 ML 337 1443118-44-2
BCC6156 MNI 137 946619-21-2
BCC7866 Xanthurenic acid Xanthurenic acid is a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus.
BCC1487 Clozapine N-oxide (CNO) Activator of muscarinic DREAADs,Clozapine N-oxide is a pharmacologically inert metabolite of Clozapine, which is a potent <b>5-HT1C</b> receptor antagonist.
BCC5702 ACPT-I 194918-76-8
BCC7344 AMN 082 dihydrochloride The first selective mGlu<sub>7</sub> agonist
BCC6550 L-AP4 L-APB is a potent and specific agonist for the group III mGluRs, with EC50s of 0.13, 0.29, 1.0, 249 μM for mGlu4, mGlu8, mGlu6 and mGlu7 receptors, respectively.
BCC7865 Cinnabarinic acid 606-59-7